VELscope Guided Oral Cancer Surgery Significantly Improves Treatment Outcomes & Survival Rate
This advanced treatment for oral cancer reduces the risk of recurrence up to 90% therefore cancer can be treated successfully and patients chances to be cured increase significantly.
VELscope Vx is the first device approved by FDA and Health Canada to be used by surgeons to help identify diseased tissue around a clinically-apparent lesion and thus aid in determining the appropriate margin for surgical excision.
VELscope Guided Surgery
This advanced treatment for oral cancer reduces the risk of recurrence up to 90% therefore cancer can be treated successfully and patients chances to be cured increase significantly.
VELscope Vx is the first device approved by FDA and Health Canada to be used by surgeons to help identify diseased tissue around a clinically-apparent lesion and thus aid in determining the appropriate margin for surgical excision.
Up to 90% reduced risk to have a second surgery gives great value for patient
Life Saved
Money Saved
Time Saved
Pain Avoided
Well determined surgical margin helps to spare healthy tissue
Function Saved
Aesthetics Saved
Faster Recovery
Less Follow-Up
Patients trust in advantages of VELscope Guided Surgery
Authentic
Credible
Proven
Evidence-based
Instant Benefits For Oral & Maxillofacial (OMFS) and Onco Surgeons
Reduce oral cancer recurrence up to 90%
• WHO recommended & FDA approved
• More effective than intraoperative FS
• Improved workflow – saved surgery time
• High success rate – satisfied patients
• Early diagnosis & Early treatment
Painless follow-up
This advanced technology to fight oral cancer has been benefiting doctors and their patients globally for years. It is backed by over $50 million in research and has been studied globally with hundreds of research papers published.
Cancer can come back if not all cancerous tissue is removed during surgery. VELscope helps doctors to see tumor borders better so all damaged tissue can be removed. Therefore, VELscope Guided Surgery reduces the risk of oral cancer recurrence by up to 90% and significantly improves treatment outcomes and survival rate.
Cancer can start from a single abnormal cell. DNA Ploidy test is powered by Artificial Intelligence (AI) technology which can find abnormal cells up to two years earlier than histology or cytology alone. Hence, mouth cancer can be diagnosed early with higher accuracy. As a result, abnormal cells can be removed early and the progression of malignancy can be stopped.
Early Signs of mouth cancer can be easily missed with the conventional examination. So better do VELscan.
VELscan comprehensive oral examination is done using VELscope device which helps doctors to see abnormalities in a mouth that can be invisible to a naked eye. This powerful technology is based on real-time auto-fluorescence imaging. Furthermore, it is recommended by WHO and approved by the FDA for early detection of pre-cancer and cancer. Routine VELscan examination is an effective way to detect early signs of mouth cancer. Treatment of early cancer can be easy and 100% successful.
Cancer can come back if not all cancerous tissue is removed during surgery.
VELscope helps doctors to see tumor borders better so all damaged tissue can be removed. Therefore, VELscope Guided Surgery reduces the risk of oral cancer recurrence by up to 90% and significantly improves treatment outcomes and survival rate.
Cancer can start from a single abnormal cell. DNA Ploidy test is powered by Artificial Intelligence (AI) technology which can find abnormal cells up to two years earlier than histology or cytology alone. Hence, mouth cancer can be diagnosed early with higher accuracy. As a result, abnormal cells can be removed early and the progression of malignancy can be stopped.
Early signs of mouth cancer can be easily missed with the conventional examination.
So better do VELscan – it saves lives.
VELscan comprehensive oral examination is done using VELscope device which helps doctors to see abnormalities in a mouth that can be invisible to a naked eye. This powerful technology is based on real-time auto-fluorescence imaging. Furthermore, it is recommended by WHO and approved by the FDA for early detection of pre-cancer and cancer. Routine VELscan examination is an effective way to detect early signs of mouth cancer. Treatment of early cancer can be easy and 100% successful.
Our solutions combine world’s most advanced real-time auto-fluorescence imaging and Artificial Intelligence AI-Powered DNA Ploidy testing to provide doctors and surgeons with unprecedented understanding of oral abnormalities.
Currently is using DNA Ploidy test and VELscope Vx to determine the appropriate surgical margin and biopsy site in his practice. As well as conducting research in the use of VELscope to assess cellular changes occurring in oral premalignancy.
I am in the field of oral oncology, performing onco-surgeries for the last 10 years, I find VELscan very useful for doctors and patients in early detection of oral cancer and better treatment outcomes.
Dr. Vijaykumar Girhe
BDS, MDS - Cranio-Maxillofacial Surgeon specializing in oncology Dr. Girhe Dental Clinic, Aurangabadwebsite
VELscope allows us to add a new dimension to detect abnormalities that may be histologic or perhaps only genetic and use those in a real-time way to evaluate surgical margins.
Prof. J. Scott Durham
Head, VGH Otolaryngology - Head and Neck Surgerywebsite
With FV technology we found that the extension of this disease is not uniform around the cancerous area, so a 10-mm margin around the tumor site may not always work. With the use of FV technology, we hope to accurately remove all cancerous tissue.
Prof. Dr. Catherine F. Poh
Prof. Dr. Catherine F. Poh, DDS, PhD, FRCD (C), Clinician Scientist, Oral Pathologist and Consulting Dentist, BC, Canadawebsite
I have got immense benefits and a lot of satisfaction using this equipment in my practice.
Dr. Prakash Patil
BDS, MDS - Oral & Maxillofacial Surgeon Face and Dental Hospital in Punewebsite
We see recurrence rate decrease significantly in both, invasive cancers and cases of severe dysplasia, when surgical margins are determined using Tissue Fluorescence Visualization.
Dr. Calum MacAulay PhD
Clinical Associate Professor, UBC Head of Integrative Oncology Distinguished Scientist Serves as Head, Cancer Imaging Department, B.C. Cancer Research Centre, BCAAwebsite
Doctors & Their Patients Love it!
Play Video
AI-Powered Advanced Technology: Win-Win For Doctors & Patients
Our solutions combine world’s most advanced real-time auto-fluorescence imaging and Artificial Intelligence AI-Powered DNA Ploidy testing to provide doctors and surgeons with unprecedented understanding of oral abnormalities.
Dr. Pushkar P Waknis Professor & Consultant Maxillofacial Surgeon MDS ( Mumbai ) FIBOMS, MFDS RCPS (Glasg) UK
Currently is using DNA Ploidy test and VELscope Vx to determine the appropriate surgical margin and biopsy site in his practice. As well as conducting research in the use of VELscope to assess cellular changes occurring in oral premalignancy.
Prof. Dr. Catherine F. Poh Prof. Dr. Catherine F. Poh, DDS, PhD, FRCD (C), Clinician Scientist, Oral Pathologist and Consulting Dentist, BC, Canada
With FV technology we found that the extension of this disease is not uniform around the cancerous area, so a 10-mm margin around the tumor site may not always work. With the use of FV technology, we hope to accurately remove all cancerous tissue.
Prof. J. Scott Durham Head, VGH Otolaryngology - Head and Neck Surgery
VELscope allows us to add a new dimension to detect abnormalities that may be histologic or perhaps only genetic and use those in a real-time way to evaluate surgical margins.
Dr. Vijaykumar Girhe BDS, MDS - Cranio-Maxillofacial Surgeon specializing in oncology Dr. Girhe Dental Clinic, Aurangabad
I am in the field of oral oncology, performing onco-surgeries for the last 10 years, I find VELscan very useful for doctors and patients in early detection of oral cancer and better treatment outcomes.
Dr. Calum MacAulay PhD Clinical Associate Professor, UBC Head of Integrative Oncology Distinguished Scientist Serves as Head, Cancer Imaging Department, B.C. Cancer Research Centre, BCAA
We see recurrence rate decrease significantly in both, invasive cancers and cases of severe dysplasia when surgical margins are determined using Tissue Fluorescence Visualization.
Dr. Prakash Patil BDS, MDS - Oral & Maxillofacial Surgeon Face and Dental Hospital in Pune
Partner With World’s Leaders And Build Your Legacy Leading The Way For Advanced Oral Cancer Care In Your Community
BUILD TRUST
Build Trust And Protect Your Reputation Providing Evidence Based Care
Case Reports - VELscope Guided Surgery
VELscope device is the world’s leading tool for enhanced oral cancer examinations. Also, it the first device approved by FDA and Health Canada to be used by surgeons to help identify diseased tissue around a clinically-apparent lesion and thus aid in determining the surgical margin better.
VELscope device is the world’s leading tool for enhanced oral cancer examinations. Also, it the first device approved by FDA and Health Canada to be used by surgeons to help identify diseased tissue around a clinically-apparent lesion and thus aid in determining the surgical margin better.
Play Video
Play Video
Play Video
We Build Strong Partnerships To Win Over Oral Cancer
We believe that no man or a woman should suffer or die to preventable cancer. We inspire families and empower doctors to reduce the risk of major disease and significantly improve survival rate.
We have a proven track record of success in oral cancer prevention, early detection, and advanced treatment. We are committed to helping doctors to succeed. We work hard to support their evolving needs, as well as the needs of the patients they serve.
We Build Strong Partnerships To Win Over Oral Cancer
We believe that no man or a woman should suffer or die to preventable cancer. We inspire families and empower doctors to reduce the risk of major disease and significantly improve survival rate.
We have a proven track record of success in oral cancer prevention, early detection, and advanced treatment. We are committed to helping doctors to succeed. We work hard to support their evolving needs, as well as the needs of the patients they serve.